Q&A With Gilmore O'Neill of Biogen International: Weighing the Options for Multiple Sclerosis Medications

Developing drugs for conditions like multiple sclerosis takes a long time and a considerable amount of research. How the drugs are used, and changed is a delicate process undertaken between doctors and their patients over the course of the disease.

Gilmore O'Neill, MD, of Biogen Interantional talked about the process of choosing the right medication and when to look at other potenial options during the American Academy of Neurology's annual meeting in Washington DC. O'Neill said some of the factors that need to be considered are whether the medication is meeting the expectations and needs of the patient and whether they are providing the treatment needed in a safe manner.